A critical discovery in cancer investigation is arising with the use of nanobodies to re-engage mutated p53. This crucial tumor suppressor protein is frequently lost in various kinds of malignancies, leading https://social-medialink.com/story7016922/mini-antibodies-reactivate-tumor-suppressor-p53-a-promising-approach-for-tumor-therapy